NICLOMED Trademark

Trademark Overview


On Friday, March 18, 2022, a trademark application was filed for NICLOMED with the United States Patent and Trademark Office. The USPTO has given the NICLOMED trademark a serial number of 97319416. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Right2Try. The NICLOMED trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements, namely, probiotic compositions; Anti-arthritic compositions and preparations; Medicaments for inhibiting the growth and metastasis of malignant cells; Medicaments for enhancing resposiveness of malignant cells to chemotherapeutic agents; Medicaments for targeting cancer linked cellular pathways and targeting mTOR, STAT3, and NF-kB and Notch pathways; Medicaments for enhancing apoptosis in cells subjected to glucose deprivation; Medicaments for enhancing ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation
niclomed

General Information


Serial Number97319416
Word MarkNICLOMED
Filing DateFriday, March 18, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7356365
Registration DateTuesday, April 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements


Goods and ServicesNutritional supplements, namely, probiotic compositions; Anti-arthritic compositions and preparations; Medicaments for inhibiting the growth and metastasis of malignant cells; Medicaments for enhancing resposiveness of malignant cells to chemotherapeutic agents; Medicaments for targeting cancer linked cellular pathways and targeting mTOR, STAT3, and NF-kB and Notch pathways; Medicaments for enhancing apoptosis in cells subjected to glucose deprivation; Medicaments for enhancing ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2022
Primary Code005
First Use Anywhere DateFriday, March 18, 2022
First Use In Commerce DateFriday, December 1, 2023

Trademark Owner History


Party NameRight2Try
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLewes, DE 19958

Party NameRight2Try
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLewes, DE 19958

Party NameRight2Try
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLewes, DE 19958

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, March 6, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 5, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, February 12, 2024USE AMENDMENT FILED
Monday, March 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 12, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 23, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Wednesday, March 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED